Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-Syndrome-Related Risk of Coronary Artery Disease
Figure 3
LDL cholesterol/Apo B ratio according to metabolic syndrome (MS) diagnosis and DEPCyMCase activity in the whole population (a) () and in subjects without lipid-lowering therapy (b) ().
